Literature DB >> 10552006

Native hepatectomy after auxiliary partial orthotopic liver transplantation.

M Kaibori1, S Uemoto, S Fujita, Y Inomata, H Egawa, K Asonuma, T Kiuchi, M Hayashi, M Nakamura, K Tanaka.   

Abstract

In countries where a living donor is the only source of the graft, the limited size of the graft is of serious concern when considering extending the procedure to adult recipients. In order to overcome this problem, auxiliary partial orthotopic liver transplantation (APOLT) was applied to the concept that the residual native liver would support the graft function until the graft expanded enough to work by itself. We herein report on a 20-year-old woman with primary sclerosing cholangitis (PSC), who received a small-size liver graft by APOLT. Computed tomography and scintigraphy showed that the graft had regenerated sufficiently 1 month after the operation. The diseased residual native liver is potentially carcinogenetic. Therefore, second-stage native hepatectomy was done 35 days after the first operation. Histopathologic examination of the resected native liver revealed biliary cirrhosis with PSC but no evidence of cholangiocarcinoma. Second-stage native hepatectomy after APOLT seems to be a curative treatment for chronic end-stage liver disease with graft size mismatch that may be as good as orthotopic liver transplantation.

Entities:  

Mesh:

Year:  1999        PMID: 10552006     DOI: 10.1007/s001470050244

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


  3 in total

Review 1.  Primary sclerosing cholangitis as an intractable disease.

Authors:  Sumihito Tamura; Yasuhiko Sugawara; Norihiro Kokudo
Journal:  Intractable Rare Dis Res       Date:  2012-02

2.  Comparative analysis of outcomes in living and deceased donor liver transplants for primary sclerosing cholangitis.

Authors:  Randeep Kashyap; Parvez Mantry; Rajeev Sharma; Manoj K Maloo; Saman Safadjou; Yanjie Qi; Ashok Jain; Benedict Maliakkal; Charlotte Ryan; Mark Orloff
Journal:  J Gastrointest Surg       Date:  2009-05-09       Impact factor: 3.452

Review 3.  Recurrence of cholestatic liver disease after living donor liver transplantation.

Authors:  Sumihito Tamura; Yasuhiko Sugawara; Junichi Kaneko; Junichi Togashi; Yuichi Matsui; Noriyo Yamashiki; Norihiro Kokudo; Masatoshi Makuuchi
Journal:  World J Gastroenterol       Date:  2008-09-07       Impact factor: 5.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.